Nonsense-mediated decay of human LDL receptor mRNA

Scandinavian Journal of Clinical and Laboratory Investigation
Øystein Lunde HollaTrine Ranheim

Abstract

The objective of this project was to determine whether nonsense mutation in the low density lipoprotein receptor (LDLR) induces nonsense-mediated mRNA decay (NMD). Four known nonsense mutations (W23X, S78X, E207X and W541X) in the LDLR gene, which are found in Norwegian familial hypercholesterolaemia (FH) patients, were investigated. Epstein-Barr virus (EBV) transformed lymphocytes from patients heterozygous for these mutations in the LDLR gene were analysed. Flow cytometric analysis was used to determine the amount and function of the cell surface LDLRs. The expression of LDLR mRNA in lymphocytes was quantified by real-time polymerase chain reaction (PCR). The presence of NMD was tested using the inhibitors gentamicin, emetine or cycloheximide. Cells from heterozygous FH patients with nonsense mutations in the LDLR gene contained significantly less LDLR protein (p<0.05). In addition, flow cytometric analysis revealed that these patients had a reduced LDL-uptake compared to controls (p<0.005). Cells from heterozygous FH patients with nonsense mutations W23X, S78X or W541X in the LDLR gene showed significantly decreased levels of LDLR mRNA (p<0.005). LDLR mRNA was reduced in the mutant lymphocyte S78X prior to treatment with pha...Continue Reading

References

Feb 1, 1990·Nature·J L Goldstein, M S Brown
Apr 4, 1986·Science·M S Brown, J L Goldstein
Jan 1, 1983·Methods in Enzymology·J L GoldsteinM S Brown
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·G M Church, W Gilbert
Jun 1, 1995·British Journal of Clinical Pharmacology·E J BeggS B Duffull
Feb 1, 1995·In Vitro Cellular & Developmental Biology. Animal·F E WallM P Moyer
Mar 1, 1997·Journal of Internal Medicine·T P LerenK Berg
Sep 2, 1999·Nature Genetics·A S Mankin, S W Liebman
May 22, 2001·Science·J L Goldstein, M S Brown
Oct 10, 2003·The New England Journal of Medicine·Michael WilschanskiEitan Kerem
Mar 26, 2004·Nature Reviews. Molecular Cell Biology·Lynne E Maquat
Jun 18, 2004·European Journal of Clinical Investigation·G V Z DedoussisC Stefanadis
Jul 31, 2004·Nature Genetics·Jill A HolbrookAndreas E Kulozik
Mar 1, 2005·Trends in Genetics : TIG·Miles F Wilkinson
Apr 30, 2005·Journal of Cell Science·Lynne E Maquat
Jun 8, 2006·European Journal of Human Genetics : EJHG·Mehrdad KhajaviJames R Lupski
Jun 20, 2006·Trends in Molecular Medicine·Holly A Kuzmiak, Lynne E Maquat
Jun 27, 2006·Trends in Molecular Medicine·Doug A BrooksJohn J Hopwood

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.